151. Staphylococcus lugdunensis prosthetic joint infection: A multicentric cohort study
- Author
-
Yannick Herry, Olivier Lesens, Gaelle Bourgeois, Mylène Maillet, Romain Bricca, Céline Cazorla, Judith Karsenty, Tomasz Chroboczek, Anissa Bouaziz, Julien Saison, Marie-Elodie Langlois, Céline Dupieux-Chabert, Tristan Ferry, and Florent Valour
- Subjects
Microbiology (medical) ,Adult ,Cohort Studies ,Arthritis, Infectious ,Infectious Diseases ,Prosthesis-Related Infections ,Treatment Outcome ,Debridement ,Staphylococcus lugdunensis ,Humans ,Aged ,Retrospective Studies ,Anti-Bacterial Agents - Abstract
To describe Staphylococcus lugdunensis prosthetic joint infection (PJI) management and outcome.Adults with proven S. lugdunensis PJI were included in a multicentric retrospective cohort. Determinants for failure were assessed by logistic regression and treatment failure-free survival curve analysis (Kaplan-Meier).One hundred and eleven patients were included (median age 72.4 [IQR, 62.7-79.4] years), with a knee (n = 71, 64.0%) or hip (n = 39, 35.1%) PJI considered as chronic in 77 (69.4%) cases. Surgical management consisted in debridement, antibiotic with implant retention (DAIR; n = 60, 54.1%), two-stage (n = 28, 25.2%) or one-stage (n = 15, 13.5%) exchange. Total duration of antimicrobial therapy was 13.1 (IQR, 11.8-16.9) weeks. After a median follow-up of 99.9 (IQR, 53.9-178.1) weeks, 22 (19.8%) S. lugdunensis-related treatment failures were observed. Independent determinants for outcome were diabetes (OR, 3.741; p = 0.036), sinus tract (OR, 3.846; p = 0.032), DAIR (OR, 3.749; p = 0.039) and rifampin-based regimen (OR, 0.319; p = 0.043). Twenty-four (40.0%) of the 60 DAIR-treated patients experienced treatment failure, with hip location (OR, 3.273; p = 0.048), delay from prosthesis implantation (OR, 1.012 per month; p = 0.019), pre-surgical CRP level115 mg/L (OR, 4.800; p = 0.039) and mobile component exchange (OR, 0.302; p = 0.069) constituting additional determinants of outcome.Staphylococcus lugdunensis PJI are difficult-to-treat infections, with pivotal roles of an optimal surgical management.
- Published
- 2021